Pfizer Ltd. (PFIZER) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 970356, "name": "Pfizer", "stock_name": "Pfizer", "full_name": "Pfizer Ltd.", "name_url": "stocks-analysis/pfizer", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "4,523.90", "chg": 22.95, "chgp": "0.51%", "dir": 1, "prev_price": "4,500.95", "mcapval": "20,695.82 Cr", "mcap": "Small Cap", "scripcode": 500680, "symbol": "PFIZER", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE182A01018", "curr_date": "Jun 18, 10:24 AM", "curr_time": "10:26 AM", "last_traded_at": "Jun 18, 10:24 AM IST", "bse_nse_vol": "3.07 k", "exc_status": "Active", "traded_date": "Jun 18, 2026", "traded_date_str": "2026 06 18", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/pfizer-970356-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Pfizer Ltd. is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/pfizer-ltd-is-rated-sell-by-marketsmojo-4051029", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/PfizerLtd_mojoScore_4051029.png", "date": "2026-06-13 10:10:21", "description": "Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Markets Rally, But Pfizer Ltd. Sinks to 52-Week Low in Stock-Specific Sell-Off", "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-stock-hits-52-week-low-at-rs4440-amidst-prolonged-underperformance-4035647", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/PfizerLtd_priceRelatedfactors_4035647.png", "date": "2026-06-04 09:50:05", "description": "Despite a broadly resilient market, Pfizer Ltd. has slipped to a fresh 52-week low of Rs 4,440 on 4 Jun 2026, marking a 22.54% decline over the past year and underperforming the Sensex by over 14 percentage points." }, { "title": "Five Consecutive Losses Push Pfizer Ltd. to a New 52-Week Low", "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-stock-hits-52-week-low-at-rs4450-amidst-broad-market-weakness-4033992", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/PfizerLtd_priceRelatedfactors_4033992.png", "date": "2026-06-03 15:36:16", "description": "For the fifth straight session, Pfizer Ltd. closed lower, breaching its 52-week low at Rs 4,450 on 3 Jun 2026, marking a significant decline amid broader market weakness." }, { "title": "Pfizer Ltd. is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/pfizer-ltd-is-rated-sell-by-marketsmojo-4030649", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/PfizerLtd_mojoScore_4030649.png", "date": "2026-06-02 10:10:19", "description": "Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Pfizer Ltd. Technical Momentum Shifts to Bearish Amid Market Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-technical-momentum-shifts-to-bearish-amid-market-pressure-4015784", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PfizerLtd_technicaldot_4015784.png", "date": "2026-05-27 08:04:24", "description": "Pfizer Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. This change is underscored by deteriorating technical indicators including MACD, Bollinger Bands, and moving averages, signalling increased selling pressure and subdued price momentum as the stock struggles to maintain its recent levels." }, { "title": "Pfizer Ltd. is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/pfizer-ltd-is-rated-sell-4004900", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PfizerLtd_mojoScore_4004900.png", "date": "2026-05-22 10:10:40", "description": "Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 May 2026, providing investors with an up-to-date view of its performance and outlook." }, { "title": "Pfizer Ltd Gains 2.66%: 3 Key Technical Shifts Shape Weekly Performance", "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-gains-266-3-key-technical-shifts-shape-weekly-performance-3994395", "imagepath": "", "date": "2026-05-16 14:02:24", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>May 11:</strong> Stock opens strong at Rs.4,876.95 (+1.37%) despite Sensex decline</p>\n <p><strong>May 13:</strong> Q4 FY26 results reveal modest growth and margin recovery</p>\n <p><strong>May 14:</strong> Technical momentum shifts to bearish amid market pressure</p>\n <p><strong>May 15:</strong> Technical momentum shows mixed signals with mild bullishness</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.4,811.05</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Clos..." }, { "title": "Pfizer Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3992064", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PfizerLtd_technicaldot_3992064.png", "date": "2026-05-15 08:00:35", "description": "Pfizer Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a recent upgrade from Hold to Sell by MarketsMOJO, the stock’s price action and technical parameters suggest a nuanced outlook for investors navigating this evolving landscape." }, { "title": "Are Pfizer Ltd. latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-pfizer-ltd-latest-results-good-or-bad-3991737", "imagepath": "", "date": "2026-05-14 19:20:18", "description": "Pfizer Ltd.'s latest financial results for the quarter ending March 2026 present a mixed operational picture. The company reported a net profit of ₹199.82 crores, reflecting a sequential increase of 40.89% compared to the previous quarter, yet this figure represents a significant decline of 39.61% year-on-year. This juxtaposition raises questions about the sustainability of its earnings growth.\n\nIn terms of revenue, Pfizer recorded ₹629.23 crores, which indicates a quarter-on-quarter decrease of 2.45% from ₹645.03 crores in December 2025. However, when viewed year-on-year, revenue has shown a growth of 6.31% from ₹591.91 crores in the same quarter last year. This suggests that while the company experienced a slight normalization in sales following a strong previous quarter, it has managed to maintain its competitive positioning in key therapeutic areas.\n\nThe operating margin stood at 37.50%, which is a sequ..." } ], "total": 371, "sid": "970356", "stock_news_url": "https://www.marketsmojo.com/news/pfizer-970356" }, "announcements": [ { "caption": "Newspaper Advertisement", "datetime": "04-Jun-2026", "details": "Please find enclosed Newspaper Advertisement for transfer of unclaimed Dividend and Shares to IEPF.", "source": "BSE" }, { "caption": "Newspaper Advertisement", "datetime": "03-Jun-2026", "details": "Special Window for Re-lodgement of Transfer and Dematerialisation of Physical Securities.", "source": "BSE" }, { "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance", "datetime": "19-May-2026", "details": "We submit herewith the Annual Secretarial Compliance Report for the financial year ended March 31 2026 issued by Parikh & Associates Practicing Company Secretaries.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Pfizer Ltd. has declared <strong>750%</strong> dividend, ex-date: 17 Jul 26", "dt": "2026-07-17", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

May 11: Stock opens strong at Rs.4,876.95 (+1.37%) despite Sensex decline

May 13: Q4 FY26 results reveal modest growth and margin recovery

May 14: Technical momentum shifts to bearish amid market pressure

May 15: Technical momentum shows mixed signals with mild bullishness

Week Open

Rs.4,811.05

Week Clos...

Read full news article

Pfizer Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-15 08:00:35

Pfizer Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a recent upgrade from Hold to Sell by MarketsMOJO, the stock’s price action and technical parameters suggest a nuanced outlook for investors navigating this evolving landscape.

Read full news article

Are Pfizer Ltd. latest results good or bad?

2026-05-14 19:20:18

Pfizer Ltd.'s latest financial results for the quarter ending March 2026 present a mixed operational picture. The company reported a net profit of ₹199.82 crores, reflecting a sequential increase of 40.89% compared to the previous quarter, yet this figure represents a significant decline of 39.61% year-on-year. This juxtaposition raises questions about the sustainability of its earnings growth. In terms of revenue, Pfizer recorded ₹629.23 crores, which indicates a quarter-on-quarter decrease of 2.45% from ₹645.03 crores in December 2025. However, when viewed year-on-year, revenue has shown a growth of 6.31% from ₹591.91 crores in the same quarter last year. This suggests that while the company experienced a slight normalization in sales following a strong previous quarter, it has managed to maintain its competitive positioning in key therapeutic areas. The operating margin stood at 37.50%, which is a sequ...

Read full news article